Cargando…

Rethinking Alzheimer’s Disease

Detalles Bibliográficos
Autor principal:	de Mendonça, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313064/ https://www.ncbi.nlm.nih.gov/pubmed/22470366 http://dx.doi.org/10.3389/fneur.2012.00045

Ejemplares similares

Rethinking of Alzheimer's disease: Lysosomal overloading and dietary therapy
por: Yuan, Shu, et al.
Publicado: (2023)

Rethinking the network determinants of motor disability in Parkinson’s disease
por: Surmeier, Dalton James, et al.
Publicado: (2023)

Rethinking the representation of sound
por: Bola, Łukasz
Publicado: (2022)

Rethinking schizophrenia in the context of normal neurodevelopment
por: Catts, Vibeke S., et al.
Publicado: (2013)

Fly model causes neurological rethink
por: Sadanandappa, Madhumala K, et al.
Publicado: (2013)

Rethinking the Conditions and Mechanism for Glymphatic Clearance
por: Ferris, Craig F.
Publicado: (2021)

Correction: Fly model causes neurological rethink
por: Sadanandappa, Madhumala K, et al.
Publicado: (2013)

Rethinking the Mechanisms Underlying the McGurk Illusion
por: Gonzales, Mariel G., et al.
Publicado: (2021)

Rethinking 1D convolution for lightweight semantic segmentation
por: Zhang, Chunyu, et al.
Publicado: (2023)

Rethinking autism: implications of sensory and movement differences for understanding and support
por: Donnellan, Anne M., et al.
Publicado: (2013)

Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection
por: Zoerle, Tommaso, et al.
Publicado: (2017)

Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer's disease
por: Santos, Jose R., et al.
Publicado: (2014)

What’s so critical about Critical Neuroscience? Rethinking experiment, enacting critique
por: Fitzgerald, Des, et al.
Publicado: (2014)

When is diminishment a form of enhancement? Rethinking the enhancement debate in biomedical ethics
por: Earp, Brian D., et al.
Publicado: (2014)

Gut-Brain Psychology: Rethinking Psychology From the Microbiota–Gut–Brain Axis
por: Liang, Shan, et al.
Publicado: (2018)

Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits
por: Amano, Shinichi, et al.
Publicado: (2015)

REMODEL: Rethinking Deep CNN Models to Detect and Count on a NeuroSynaptic System
por: Shukla, Rohit, et al.
Publicado: (2019)

Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models
por: Foldi, Claire J., et al.
Publicado: (2020)

Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model
por: Zhou, Chunhua, et al.
Publicado: (2020)

Rethinking statistical learning as a continuous dynamic stochastic process, from the motor systems perspective
por: Vaskevich, Anna, et al.
Publicado: (2022)

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
por: Souchet, Benoit, et al.
Publicado: (2018)

Rethinking the detection and diagnosis of Alzheimer’s disease: Outcomes of a European Brain Council project
por: Dumas, Annette, et al.
Publicado: (2023)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Rethinking disability: The need to rethink representation
por: Procter, Jenna-Lee
Publicado: (2018)

Insulin Resistance in Alzheimer's Disease
por: Ferreira, Laís S. S., et al.
Publicado: (2018)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Alzheimer's Disease and Anesthesia
por: Papon, Marie-Amélie, et al.
Publicado: (2011)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

Propionate and Alzheimer’s Disease
por: Killingsworth, Jessica, et al.
Publicado: (2021)

Epigenetics in Alzheimer’s Disease
por: Gao, Xiaodie, et al.
Publicado: (2022)

Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma
por: Vallée, Alexandre, et al.
Publicado: (2016)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Erratum: Rethinking disability: The need to rethink representation
por: Procter, Jenna-Lee
Publicado: (2019)

Rethinking fatigue in Gaucher disease
por: Zion, Y. Chen, et al.
Publicado: (2016)

Rethinking monogenic neurological diseases
por: Chen, Wan-Jin, et al.
Publicado: (2020)

Prodromal Alzheimer’s Disease: Constitutive Upregulation of Neuroglobin Prevents the Initiation of Alzheimer’s Pathology
por: de Vidania, Silvia, et al.
Publicado: (2020)

The emerging neuroprotective roles of exerkines in Alzheimer’s disease
por: Rody, Tayna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7kgt0804mvm3h7atib1otr2la4